# Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization

> **NCT01566175** · NA · RECRUITING · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Refractory Angina

## Interventions

- **DEVICE:** Neovac coronary sinus reducer

## Key facts

- **NCT ID:** NCT01566175
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2011-08-30
- **Primary completion:** 2030-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01566175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01566175, "Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01566175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*